Showing results (1611-1620 of 1,662) with videos related to

Sort By:
Pageof 167
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE TrialMina S Sedrak, Can-Lan Sun, Jingran Ji, et al.
International Journal of Technology Assessment in Health Care|June 2, 2025
Defining early health technology assessment: building consensus using Delphi techniqueJanneke P C Grutters, Janet Bouttell, Payam Abrishami, et al.
BMC Genomics|April 13, 2016
Gene expression comparison of resistant and susceptible Atlantic salmon fry challenged with Infectious Pancreatic Necrosis virus reveals a marked contrast in immune responseDiego Robledo, John B Taggart, Jacqueline H Ireland, et al.
Journal of Medicinal Chemistry|July 20, 2007
Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophoreJoseph P Marino, Paul W Fisher, Glenn A Hofmann, et al.
Gynecologic Oncology|June 8, 2026
Psychometric evaluation of the NFOSI-18 disease related symptoms - Physical, NFOSI-18 Total, and FACT GP5 in the recurrent ovarian cancer phase III study GY004Xiaodan Tang, Helen Huang, John D Peipert, et al.
Plos One|April 27, 2013
HER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancerWen-Yee Chay, Sung-Hock Chew, Whee-Sze Ong, et al.
World Neurosurgery|March 3, 2012
A multicenter, single-blind, prospective randomized trial to evaluate the safety of a polyethylene glycol hydrogel (Duraseal Dural Sealant System) as a dural sealant in cranial surgeryJoshua W Osbun, Richard G Ellenbogen, Randall M Chesnut, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2022
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III TrialJoyce F Liu, Mark F Brady, Ursula A Matulonis, et al.
Applied Health Economics and Health Policy|September 16, 2024
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of DiabetesTing Zhao, Michelle Tew, Talitha Feenstra, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2020
Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes ChallengeLei Si, Michael S Willis, Christian Asseburg, et al.
Pageof 167